The National Cancer Society Malaysia (NCSM) has made an urgent case for a coordinated national screening programme to tackle the growing burden of cardio-renal-metabolic diseases—a dangerous combination of heart disease, kidney dysfunction, and metabolic disorders including diabetes—that increasingly threatens public health across the country. The appeal comes as Malaysia grapples with escalating rates of these interconnected conditions, which frequently occur together and accelerate each other's progression through shared physiological pathways.
Evidence underpinning the call emerges from a substantial community health initiative conducted in the Klang Valley during the previous year. The NCSM-Boehringer Ingelheim Saring@Komuniti Project, which examined 5,000 individuals residing in underserved areas with backing from the Ministry of Health, uncovered a pervasive hidden disease burden across these populations. Nearly nine in ten participants harboured two or more cardio-renal-metabolic risk factors simultaneously, underscoring the complex nature of chronic disease in Malaysia and the inadequacy of disease-specific approaches to public health.
The project's quantitative findings paint a sobering picture of metabolic dysfunction spreading through vulnerable communities. Results indicated that 41.3 per cent of the screened group were classified as obese, with a further 28.8 per cent overweight. Glucose metabolism problems emerged as particularly prevalent: 34.5 per cent exhibited pre-diabetes while 35.1 per cent had already progressed to diabetes, suggesting widespread dysglycemia across these populations. Most strikingly, 97.8 per cent of all participants demonstrated at least one cardio-renal-metabolic risk factor, indicating that exposure to these health threats has become nearly universal among the communities examined.
The national health trajectory supporting these warnings is deeply concerning. Chronic kidney disease prevalence has surged dramatically—rising from 9.1 per cent of the population in 2011 to 15.5 per cent by 2019—whilst the number of Malaysians requiring dialysis has more than tripled across two decades. These figures reflect not merely statistical change but growing numbers of individuals dependent on intensive medical interventions, placing mounting strain on healthcare infrastructure and resources. Without systemic intervention, healthcare systems throughout Malaysia face accelerating demand for expensive, long-term treatments that could have been prevented through earlier detection.
The fundamental challenge identified by NCSM and supporting healthcare professionals stems from fragmentation within Malaysia's current healthcare architecture. Existing approaches typically address individual diseases in isolation—treating hypertension separately from diabetes, and both separately from kidney disease—thereby missing crucial opportunities to identify overlapping risks and implement unified prevention strategies. This siloed methodology obscures the interconnected nature of these conditions and leaves patients vulnerable to cascading complications as one condition exacerbates another.
Equally problematic are the structural weaknesses in patient care pathways following initial detection. Many individuals receive abnormal screening results but encounter inconsistent follow-up mechanisms, fragmented referral systems, and barriers to continuous care that impede timely intervention. Between detection and sustained treatment, patients frequently fall through organisational gaps, with referrals delayed, appointments missed, and necessary continuity of care disrupted. These systemic failures transform potentially preventable disease progressions into irreversible health deterioration.
To remedy these interconnected problems, NCSM's policy briefs advance concrete recommendations centring on two strategic pillars. First, Malaysia should systematically expand integrated co-screening programmes nationwide, embedding standardised cardio-renal-metabolic risk assessments into routine health examinations rather than requiring separate, disease-specific screening visits. This consolidation approach would enable detection of the full spectrum of risk factors during single encounters, improving efficiency whilst reducing barriers to comprehensive assessment. Second, the healthcare system must strengthen care continuity mechanisms, ensuring that individuals seamlessly transition from screening results through diagnosis, initiation of treatment, and sustained long-term disease management with coordinated follow-up.
Dr Murallitharan Munisamy, Managing Director of NCSM, articulated the organisational vision underlying these recommendations: Malaysia possesses a genuine opportunity to fundamentally restructure its chronic disease response, shifting away from managing isolated cardiovascular, renal, and metabolic conditions toward addressing these interconnected health challenges as a unified continuum. Early detection, however, remains insufficient alone—it must be paired with coordinated follow-up arrangements and enduring support systems if Malaysia is to genuinely improve health outcomes and stem the expanding chronic disease burden consuming healthcare resources.
The pharmaceutical perspective reinforces this integrated framework. Cheong Yee Kok, General Manager and Head of Human Pharma at Boehringer Ingelheim Malaysia, Singapore, and Indonesia, emphasised that cardiovascular, kidney, and metabolic conditions constitute an inseparable ecosystem where each component amplifies others' destructive potential. This characterisation challenges Malaysian policymakers to reconsider conventional healthcare delivery models organised around discrete disease categories.
For Malaysian policymakers and health administrators, the implications extend beyond epidemiological concern. The burden of escalating chronic disease directly threatens the sustainability of public healthcare financing, workforce capacity, and patient outcomes across the nation. Implementation of integrated screening strategies represents not merely a clinical improvement but an essential reform for maintaining health system viability whilst protecting population wellbeing. The window for preventive intervention narrows as disease prevalence accelerates, making the timing of NCSM's appeal particularly critical for Malaysia's health future.
